FDA Approved: GABAPENTIN — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' original application for a generic gabapentin, enabling a generic version to be marketed for the same indications as the r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)